Free Trial

National Securities' Rating of iHuman on 12/24/2020

On December 24, 2020, National Securities updated its outlook on iHuman (NYSE:IH) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from National Securities

DateCompanyAction
6/18/2021
JOYY Inc. stock logo
YY
JOYY
Reiterated Rating
2/9/2021
Oramed Pharmaceuticals Inc. stock logo
ORMP
Oramed Pharmaceuticals
Initiated Coverage
1/26/2021
Genprex stock logo
GNPX
Genprex
Initiated Coverage
12/24/2020
iQIYI, Inc. Sponsored ADR stock logo
IQ
iQIYI
Reiterated Rating
12/23/2020
Humanigen, Inc. stock logo
HGEN
Humanigen
Initiated Coverage
12/21/2020
RigNet, Inc. stock logo
RNET
RigNet
Downgrade
More Ratings From National Securities